Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.

Abstract : Coactivator-associated arginine methyltransferase 1 (CARM1) represents a valuable target for hormone-dependent tumors such as prostate and breast cancers. Here we report the enzyme and cellular characterization of the 1-benzyl-3,5-bis(3-bromo-4-hydroxybenzylidene)piperidin-4-one (7g) and its analogues 8a-l. Among them, 7g, 8e, and 8l displayed high and selective CARM1 inhibition, with lower or no activity against a panel of different PRMTs or HKMTs. In human LNCaP cells, 7g showed a significant dose-dependent reduction of the PSA promoter activity.
Document type :
Journal articles
Complete list of metadatas

Cited literature [24 references]  Display  Hide  Download

https://hal-riip.archives-ouvertes.fr/pasteur-00968654
Contributor : Istituto Pasteur Fondazione Cenci Bolognetti <>
Submitted on : Tuesday, April 1, 2014 - 12:48:45 PM
Last modification on : Thursday, August 22, 2019 - 4:26:01 PM
Long-term archiving on : Monday, April 10, 2017 - 8:16:11 AM

File

Chengetal2011.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Donghang Cheng, Sergio Valente, Sabrina Castellano, Gianluca Sbardella, Roberto Di Santo, et al.. Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.. Journal of Medicinal Chemistry, American Chemical Society, 2011, 54 (13), pp.4928-32. ⟨10.1021/jm200453n⟩. ⟨pasteur-00968654⟩

Share

Metrics

Record views

107

Files downloads

364